雅培® ID NOW™ COVID-19 快速分子检测与豪洛捷® Panther Aptima™ SARS-CoV-2 检测在鼻咽标本中的比较：急诊科为期 1 年的回顾性研究结果。
Abbott® ID NOW™ COVID-19 rapid molecular assay versus Hologic® Panther Aptima™ SARS-CoV-2 assay in nasopharyngeal specimens: results from 1-year retrospective study in an emergency department.
机构信息
Microbiology unit, Begin teaching military hospital, Saint-Mandé, France.
Microbiology unit, Begin teaching military hospital, Saint-Mandé, France.
出版信息
Diagn Microbiol Infect Dis. 2022 Sep;104(1):115742. doi: 10.1016/j.diagmicrobio.2022.115742. Epub 2022 Jun 12.
Abstract
We compared ID Now™ and Hologic® Panther Aptima™ for the detection of SARS-COV-2. ID Now™ showed a positive and negative percent agreement of 86.9% and 99.7% respectively. This facilitates faster clinical decision-making, along with the rapid implementation of infection control measures, and improvement of patient flow in the emergency department toward inpatient wards.
摘要
我们比较了 ID Now™ 和 Hologic® Panther Aptima™ 检测 SARS-COV-2 的效果。ID Now™ 的阳性和阴性符合率分别为 86.9%和 99.7%。这有助于更快地做出临床决策，以及快速实施感染控制措施，改善急诊部门向住院病房的患者流程。
相似文献
1
Abbott® ID NOW™ COVID-19 rapid molecular assay versus Hologic® Panther Aptima™ SARS-CoV-2 assay in nasopharyngeal specimens: results from 1-year retrospective study in an emergency department.
Diagn Microbiol Infect Dis. 2022 Sep;104(1):115742. doi: 10.1016/j.diagmicrobio.2022.115742. Epub 2022 Jun 12.
2
Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens.
J Clin Virol. 2020 Aug;129:104541. doi: 10.1016/j.jcv.2020.104541. Epub 2020 Jul 6.
3
Characteristics of the ID-NOW™ test for the rapid detection of SARS-CoV-2.
Epidemiol Mikrobiol Imunol. 2023 Winter;72(1):3-8.
4
Abbott ID NOW™ COVID-19 assay: do not discard the swab.
Diagn Microbiol Infect Dis. 2023 Apr;105(4):115832. doi: 10.1016/j.diagmicrobio.2022.115832. Epub 2022 Oct 13.
5
One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW™.
J Clin Virol. 2021 Aug;141:104896. doi: 10.1016/j.jcv.2021.104896. Epub 2021 Jun 12.
6
The diagnostic accuracy of the ID NOW COVID-19 point of care test in acute hospital admissions.
J Clin Virol. 2024 Feb;170:105634. doi: 10.1016/j.jcv.2023.105634. Epub 2023 Dec 13.
7
Clinical evaluation of a modified SARS-CoV-2 rapid molecular assay, ID NOW ™ COVID-19 2.0.
J Infect Chemother. 2024 Sep;30(9):955-957. doi: 10.1016/j.jiac.2024.02.032. Epub 2024 Mar 2.
8
Analytical performance of the Abbott ID NOW 2.0 assay for SARS-CoV-2 detection in clinical samples from symptomatic patients.
Diagn Microbiol Infect Dis. 2024 Mar;108(3):116164. doi: 10.1016/j.diagmicrobio.2023.116164. Epub 2023 Dec 21.
9
Comparison of performance between three SARS-CoV-2 molecular assays (Aptima™, Laboratory Developed Test-Fusion, and R-GENE®) with special attention to turnaround time, a key point in laboratory management.
J Med Virol. 2022 Jul;94(7):3399-3403. doi: 10.1002/jmv.27675. Epub 2022 Mar 7.
10
Clinical Evaluation and Utilization of Multiple Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2.
Am J Clin Pathol. 2020 Jul 7;154(2):201-207. doi: 10.1093/ajcp/aqaa097.
本文引用的文献
1
A brief performance evaluation and literature review of Abbott ID Now COVID-19 rapid molecular-based test.
J Virol Methods. 2021 Dec;298:114293. doi: 10.1016/j.jviromet.2021.114293. Epub 2021 Sep 20.
2
Comparison of diagnostic performance of five molecular assays for detection of SARS-CoV-2.
Diagn Microbiol Infect Dis. 2021 Dec;101(4):115518. doi: 10.1016/j.diagmicrobio.2021.115518. Epub 2021 Aug 6.
3
Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01136-20.
4
Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2.
J Clin Virol. 2020 Jul;128:104428. doi: 10.1016/j.jcv.2020.104428. Epub 2020 May 13.
5
Five-minute point-of-care testing for SARS-CoV-2: Not there yet.
J Clin Virol. 2020 Jul;128:104410. doi: 10.1016/j.jcv.2020.104410. Epub 2020 May 1.
6
Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2.
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00783-20.
7
Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients.
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00798-20.
8
Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19.
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00760-20.
Zotero 插件